4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001104659-16-162787
CEO bought 4,750 shares at an average $2.09 ($9,944)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WELCH WILLIAM J CEO | 2016-12-16 | Purchase | +2,500 | $2.10 | $5,250 | 2,500 | D: show line 1 in the form |
| WELCH WILLIAM J CEO | 2016-12-16 | Purchase | +2,250 | $2.09 | $4,694 | 4,750 | D: show line 2 in the form |
| Open-market purchases · 4,750 sh · avg $2.09 · $9,944 | |||||||
Loading xslF345X03/a4.xml…